MSB 3.21% $1.13 mesoblast limited

Morningstar $2.10 valuation, page-60

  1. 5,487 Posts.
    lightbulb Created with Sketch. 8943
    Hi Col

    I have a sizeable stake in starpharma which I took up more recently, and am aware they have a fast track designation of their own!

    So lots to be excited about, and I am sure I will gravitate over once some news starts flowing. And I believe the AstraZeneca partnership will continue to bear fruit for a while yet.

    It is just that MSB have some seriously important announcements coming up in weeks and months and I have been following this stock for a while longer.

    The markets that MSB are targeting are also much larger than SPL, but SPL are in a better cash position. So risk/reward i am excited about both.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.